Novavax

Novavax is a late-stage biotechnology company dedicated to improving health globally through the discovery, development, and commercialization of innovative vaccines.

Stage

Grant

Employees

1,001-5,000

Links

Org chart

Stanley C. Erck
President & CEO
Collapse
Gregory M. Glenn
President, Research & Development
Rick Crowley
EVP, COO
Jim Kelly
EVP, CFO & Treasurer
Biegie Lee
SVP, CIO
John J. Trizzino
EVP, Chief Commercial Officer & Chief Business Officer
Filip Dubovsky
EVP, Chief Medical Officer
Russell P. Wilson
EVP & GM, Influenza
Henrietta Ukwu
SVP, Chief Regulatory & Quality Officer
Gale E. Smith
SVP, Discovery & Pre-clinical Research & Chief Scientist
John A. Herrmann III
EVP, Chief Legal Officer & Corporate Secretary
Jill Hoyt
EVP, Chief Human Resources Officer
Raburn Mallory
SVP, Clinical Development
Denny Kim
SVP, Chief Safety Officer
Seth Toback
SVP, Medical Affiars
Marco Cacciuttolo
SVP. Process & Analytical Development